NoNO-42 Trial in Acute Ischemic Stroke Patients Selected for Thrombolysis With or Without Endovascular Thrombectomy

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 600 participants.

Also called NCT06403267

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 600 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06403267
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06403267. Randomized; no masking; primary purpose treatment. Start 2024-10-02 (actual); primary completion 2026-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
NoNO-42 Trial in Acute Ischemic Stroke Patients Selected for Thrombolysis With or Without Endovascular Thrombectomy
Condition
Acute Ischemic Stroke
Intervention (Drug)
NoNO-42
Lead sponsor
NoNO Inc. (class: industry)
Collaborator
University of Calgary (class: other)

Record details

Record id
cardio:ct-nct06403267
Content hash
38001657fe4ed6c886735fe74119df5c90118a4b9bdc1b0ecb90fd43838c22e9